Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Budesonide

EU orphan designation number: EU/3/13/1181   
Active ingredient: Budesonide
Indication: Treatment of eosinophilic oesophagitis
Sponsor: Dr. Falk Pharma GmbH
Leinenweberstrasse 5, D-79108 Freiburg im Breisgau, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Centralised Orphan - Designation EMA/OD/078/13 (2013)5280 of 05/08/2013
01/10/2013 Corrigendum (2013)6438 of 27/09/2013